Skip to search formSkip to main contentSkip to account menu

CSL112

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
CSL112 (apolipoprotein A‐I [human]) is a novel intravenous formulation of plasma‐derived apolipoprotein A‐I (apoA‐I) that… 
2015
2015
We have previously shown that reconstituted HDL has the ability to inactivate phospholipid hydroperoxides (PLOOH) in oxidized LDL… 
2014
2014
Introduction: CSL112 is apolipoprotein A-I (apoA[[Unable to Display Character: ‐]]I) purified from human plasma and reconstituted… 
2013
2013
Purpose: The ability of HDL to promote cholesterol efflux from atherosclerotic plaque is thought to underpin its potential for…